Shanghai Rendu Biotechnology Co. Ltd. A (688193) — Cash Flow Quality Index
Shanghai Rendu Biotechnology Co. Ltd. A (688193) has a Cash Flow Quality Index of 2.22x as of December 2025. Operating cash flow of CN¥22.41 Million exceeds net income of CN¥10.09 Million, indicating high earnings quality where cash backs reported profits. Explore 688193 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Shanghai Rendu Biotechnology Co. Ltd. A Cash Flow Quality Index (2019–2025)
Historical Cash Flow Quality Index for Shanghai Rendu Biotechnology Co. Ltd. A across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 688193 cash generation efficiency.
Annual Cash Flow Quality Index for Shanghai Rendu Biotechnology Co. Ltd. A (2019–2025)
Year-by-year earnings quality comparison for Shanghai Rendu Biotechnology Co. Ltd. A.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.22x | CN¥22.41 Million | CN¥10.09 Million | ▲ +6.7% |
| 2023 | 2.08x | CN¥17.19 Million | CN¥8.26 Million | ▲ +1287.0% |
| 2022 | -0.18x | CN¥-4.09 Million | CN¥23.33 Million | ▼ -120.8% |
| 2021 | 0.84x | CN¥54.44 Million | CN¥64.62 Million | ▼ -44.2% |
| 2020 | 1.51x | CN¥92.61 Million | CN¥61.38 Million | ▼ -58.7% |
| 2019 | 3.65x | CN¥13.67 Million | CN¥3.74 Million | — |